94 related articles for article (PubMed ID: 2721567)
1. A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260.
Lotti VJ; Chang RS
Eur J Pharmacol; 1989 Mar; 162(2):273-80. PubMed ID: 2721567
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin and Somatostatin Negatively Affect Growth of the Somatostatin-RIN-14B Cells.
El-Kouhen K; Morisset J
Int J Endocrinol; 2009; 2009():875167. PubMed ID: 20011057
[TBL] [Abstract][Full Text] [Related]
3. Cholecystokinin-2/gastrin antagonists: 5-hydroxy-5-aryl-pyrrol-2-ones as anti-inflammatory analgesics for the treatment of inflammatory bowel disease.
Lattmann E; Sattayasai J; Narayanan R; Ngoc N; Burrell D; Balaram PN; Palizdar T; Lattmann P
Medchemcomm; 2017 Mar; 8(3):680-685. PubMed ID: 30108786
[TBL] [Abstract][Full Text] [Related]
4. The Cholecystokinin Type 2 Receptor, a Pharmacological Target for Pain Management.
Bernard A; Danigo A; Bourthoumieu S; Mroué M; Desmoulière A; Sturtz F; Rovini A; Demiot C
Pharmaceuticals (Basel); 2021 Nov; 14(11):. PubMed ID: 34832967
[TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin and psychiatric disorders : role in aetiology and potential of receptor antagonists in therapy.
Shlik J; Vasar E; Bradwejn J
CNS Drugs; 1997 Aug; 8(2):134-52. PubMed ID: 23338219
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis for binding and subtype selectivity of 1,4-benzodiazepine antagonist ligands of the cholecystokinin receptor.
Cawston EE; Lam PC; Harikumar KG; Dong M; Ball AM; Augustine ML; Akgün E; Portoghese PS; Orry A; Abagyan R; Sexton PM; Miller LJ
J Biol Chem; 2012 May; 287(22):18618-35. PubMed ID: 22467877
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide regulation of fear and anxiety: Implications of cholecystokinin, endogenous opioids, and neuropeptide Y.
Bowers ME; Choi DC; Ressler KJ
Physiol Behav; 2012 Dec; 107(5):699-710. PubMed ID: 22429904
[TBL] [Abstract][Full Text] [Related]
8. Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases.
Berna MJ; Jensen RT
Curr Top Med Chem; 2007; 7(12):1211-31. PubMed ID: 17584143
[TBL] [Abstract][Full Text] [Related]
9. Bombesin-induced gastroprotection.
West SD; Mercer DW
Ann Surg; 2005 Feb; 241(2):227-31. PubMed ID: 15650631
[TBL] [Abstract][Full Text] [Related]
10. New CCK2 agonists confirming the heterogeneity of CCK2 receptors: characterisation of BBL454.
Bellier B; Crété D; Million ME; Beslot F; Bado A; Garbay C; Daugé V
Naunyn Schmiedebergs Arch Pharmacol; 2004 Nov; 370(5):404-13. PubMed ID: 15480577
[TBL] [Abstract][Full Text] [Related]
11. PD-136,450: a CCK2 (gastrin) receptor antagonist with antisecretory, anxiolytic and antiulcer activity.
Bastaki SM; Hasan MY; Chandranath SI; Schmassmann A; Garner A
Mol Cell Biochem; 2003 Oct; 252(1-2):83-90. PubMed ID: 14577579
[TBL] [Abstract][Full Text] [Related]
12. New molecular targets for treatment of peptic ulcer disease.
Lehmann F; Hildebrand P; Beglinger C
Drugs; 2003; 63(17):1785-97. PubMed ID: 12921485
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models.
Rotzinger S; Vaccarino FJ
J Psychiatry Neurosci; 2003 May; 28(3):171-81. PubMed ID: 12790157
[TBL] [Abstract][Full Text] [Related]
14. Identification of a series of CCK-2 receptor nonpeptide agonists: sensitivity to stereochemistry and a receptor point mutation.
Kopin AS; McBride EW; Chen C; Freidinger RM; Chen D; Zhao CM; Beinborn M
Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5525-30. PubMed ID: 12697901
[TBL] [Abstract][Full Text] [Related]
15. Evidence that histamine homologues discriminate between H3-receptors in guinea-pig cerebral cortex and ileum longitudinal muscle myenteric plexus.
Harper EA; Shankley NP; Black JW
Br J Pharmacol; 1999 Oct; 128(3):751-9. PubMed ID: 10516658
[TBL] [Abstract][Full Text] [Related]
16. Small synthetic ligands of the cholecystokinin-B/gastrin receptor can mimic the function of endogenous peptide hormones.
Beinborn M; Chen C; DeMeo L; McBride EW; Kopin AS
Yale J Biol Med; 1998; 71(3-4):337-46. PubMed ID: 10461364
[TBL] [Abstract][Full Text] [Related]
17. Interactions between cholecystokinin and opioids in the isolated guinea-pig ileum.
Romanelli L; Amico MC; Mattioli F; Morrone LA; Valeri P
Br J Pharmacol; 1999 Jun; 127(4):909-18. PubMed ID: 10433498
[TBL] [Abstract][Full Text] [Related]
18. L-365,260 inhibits in vitro acid secretion by interacting with a PKA pathway.
Oiry C; Pannequin J; Cormier A; Galleyrand JC; Martinez J
Br J Pharmacol; 1999 May; 127(1):259-67. PubMed ID: 10369481
[TBL] [Abstract][Full Text] [Related]
19. Antisecretory and ulcer healing effects of S-0509, a novel CCK-B/gastrin receptor antagonist, in rats.
Amagase K; Ikeda K; Okabe S
Dig Dis Sci; 1999 May; 44(5):879-88. PubMed ID: 10235591
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the binding of a novel radioligand to CCKB/gastrin receptors in membranes from rat cerebral cortex.
Harper EA; Shankley NP; Black JW
Br J Pharmacol; 1999 Mar; 126(6):1504-12. PubMed ID: 10217546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
